Targeting the cytoskeleton against metastatic dissemination

Area of Science:

• Cell Biology
• Oncology
• Biochemistry

Background:

• Cancer is characterized by abnormal cell behavior, including enhanced migration and invasion.
• The cytoskeleton, crucial for cell shape and motility, is deregulated in malignancy.
• Metastasis causes 90% of cancer deaths, with limited effective treatments.

Purpose of the Study:

• To review the role of cytoskeleton components and associated proteins in cancer metastasis.
• To highlight the potential of targeting the cytoskeleton for anti-metastasis drug development.
• To focus on small molecules affecting actin organization and function, while also considering microtubules and intermediate filaments.

Main Methods:

• Literature review and synthesis of existing research on cytoskeleton and cancer metastasis.
• Analysis of the involvement of actin, microtubules, and intermediate filaments in cancer progression.
• Examination of small molecule compounds targeting cytoskeleton dynamics.

Main Results:

• Cytoskeleton deregulation is a key driver of cancer cell invasion and metastasis.
• Actin cytoskeleton organization and function are critical for the metastatic phenotype.
• Microtubules and intermediate filaments also play significant roles in cancer spread.

Conclusions:

• The cytoskeleton represents a promising therapeutic target for combating cancer metastasis.
• Developing drugs that interfere with cytoskeleton dynamics could lead to effective anti-metastatic therapies.
• Further research into cytoskeleton-targeting agents is warranted for advanced cancer treatment.